Latest Articles

Conducting BE Studies for NTI Drugs

Conducting BE Studies for NTI Drugs

Here’s a detailed explanation of how bioequivalence (BE) studies are conducted for narrow therapeutic index (NTI) drugs, including regulatory expectations, study design, analytical methods, and statistical analysis: Detailed Overview: Bioequivalence … Read More

DCP vs. MRP | Choosing the Right Regulatory Pathway in the EU

Handling Conflicting Regulatory Requirements | A Strategic Approach

The Secrets of Good Peak Shape in HPLC

Ways to Extend the Lifespan of C18 Columns & Guard Columns

Trending Now

Key Considerations for Generic Formulation Development

Oral Vs Parenteral Dosage Form | Formulation Challenges

Optimizing Particle Size Distribution (PSD) for Tablet Formulations

Formulation Development Strategy for BCS Class IV Molecules

Formulation Development Strategy for BCS Class III Molecules

Pharmacy Exam

Saudi Pharmacist Licensure Examination (SPLE) Syllabus

KAPS Exam Syllabus

Knowledge Assessment of Pharmaceutical Sciences (KAPS) Exam

Saudi Pharmacist Licensure Examination (SPLE)

Disease Management

Osteoarthritis Management Guidelines

COPD Management Guidelines

Diabetes Management Guidelines

Obesity Management Guidelines

Drug Digest

Prednisolone | Drug Digest

LYRICA (Pregabalin) | Drug Digest

ACCUTANE (Isotretinoin) | Drug Digest

Metformin Tablets | Drug Digest

academia

‣Citric Acid Cycle: A Journey Into Cellular Metabolism

‣Types of Drug Antagonism

‣Factors Affecting Rate of Gastrointestinal Absorption

‣Absorption of Drugs from Alimentary Tract

‣Types of Drug Receptor Binding

Read More »

basic Pharmacy

‣Physicochemical Properties of Drugs

‣Three Systems of Measurement Used in Pharmacy

‣Unit of Measurement in Pharmacy Practices

‣How to Increase Solubility of Drug?

‣Introduction to Drug Discovery

Read More »

clinical Pharmacy

‣Novel Polymers in Drug Delivery

‣Biodegradable Polymers in Drug Delivery

‣Nanotechnology in Drug Formulation

‣General Adverse Events in Clinical Trials

‣Pharmacokinetics of Naproxen

Read More »

industrial Pharmacy

‣Conducting BE Studies for NTI Drugs

‣DCP vs. MRP | Choosing the Right Regulatory Pathway in the EU

‣Handling Conflicting Regulatory Requirements | A Strategic Approach

‣Ways to Extend the Lifespan of C18 Columns & Guard Columns

‣Seamless Technology Transfer in Topical Products

Read More »

audit & inspection

‣US FDA Inspection and SMEs Role

‣Essential Skills for Pharma Auditors in Today’s Regulatory Landscape

‣Audits and Inspections in Pharmaceutical Industries | Similarities and Differences

‣Common Terms Used in USFDA Inspections

‣FDA Inspection and Findings on Current Good Manufacturing Practice (CGMP)

Read More »

automation

‣Validation of ERP System

‣Difference Between Industry 1.0, 2.0, 3.0 and 4.0

‣Re-Validation in Computerized System Validation (CSV)

‣Validation of a SCADA System Within CSV

‣How to Handle CSV in Pharmaceutical Industry

Read More »

DATA INTEGRITY

‣Microbiological Data Integrity Issues and Control Strategies

‣Data Integrity in Pharmaceutical Industry

‣Data Integrity in Analytical Laboratories

‣Objective of Data Management and Integrity in Pharmaceutical Industry

‣Frequently Asked Questions on Data Integrity

Read More »

pharma guidelines

‣Comprehensive List of Pharmaceutical Guidelines

‣Facility Readiness Goal Date Decisions Under GDUFA

‣Explanation of FDA Designations

‣EU and US GMPs | Understanding the Similarities and Differences

‣Common Terms Used in USFDA Inspections

Read More »